Login
Cardinal Health NYSE: CAH
Cardinal Health has a wide range of professional medical products from anesthesia-related equipment to laboratory products down to consumables such as gloves
| Name | Cardinal Health |
| Ticker | CAH |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Medical Consumables & Intermediates |
|
Price
52W Low/High |
59.20
45.25 / 62.46 |
| Momentum | Neutral |
| Market cap | 17 B |
| 1Y Total Return |
7.37 %
Subpar |
| 1Y Volatility |
29.43 %
Below Average |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Cardinal Health has a wide range of professional medical products from anesthesia-related equipment to laboratory products down to consumables such as gloves
Details
| Ticker | CAH |
| Name | Cardinal Health |
| ISIN | US14149Y1082 |
| CUSIP | 14149Y108 |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Medical Consumables & Intermediates |
| Country | USA |
| Currency | U.S. Dollar |
Share as of 07/23/2021
| Close Price | 59.20 |
| 52W Low/High | 45.25 / 62.46 |
| Market cap | 17 B |
| 1Y Total Return |
7.37 %
Subpar |
| 1Y Volatility |
29.43 %
Below Average |
| Beta | 1.52 |
| PE (trailing) |
15.18
Below Average |
| 12M Dividends | 1.944 |
| Last Dividend Date | 06/30/2021 |
| Dividend Yield | 3.28 % |
Fin. Strength
| Net Profit Margin | 0.7 % |
| Cash from Op. / Cur. Liabilities | 0.08 |
| Diluted Earnings / Share | 3.90 |
| ROE | 76.9 % |
| ROIC | 8.0 % |
| Price / Revenue | 0.1 |
| Price / Book | 9.7 |
| Price / CF | 8.7 |
| Current Ratio | 1.2 |
| Cur.Liabilities / Tot.Liabilities | 0.6 |
| Financial Leverage | 3.76 |
| in Mils USD |
rolling-year up to March
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| Revenue |
156,570
|
153,586
|
143,530
|
134,426
|
128,394
|
117,710
|
|
| Gross Profit |
6,893
|
6,952
|
6,896
|
7,069
|
6,586
|
6,335
|
|
| R&D |
0
|
0
|
0
|
0
|
0
|
0
|
|
| EBITDA |
2,029
|
-3,166
|
1,642
|
2,618
|
2,999
|
2,974
|
|
| Operating Income |
633
|
-4,083
|
632
|
1,654
|
2,303
|
2,392
|
|
| Net Income exc. Extra |
1,151
|
-
|
3
|
1,697
|
1,346
|
1,390
|
|
| per Share | |||||||
| Diluted avg Shares |
294
|
294
|
299
|
315
|
318
|
331
|
|
| EPS exc. Extra |
3.90
|
-14.06
|
0.17
|
5.36
|
4.20
|
4.18
|
|
| Dividend |
1.94
|
1.92
|
1.91
|
1.85
|
1.80
|
1.55
|
|
| Div. Yield (an.) |
3.20 %
|
4.01 %
|
3.96 %
|
2.95 %
|
2.20 %
|
1.89 %
|
|
| Balance Sheet | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| Total Assets |
43,874
|
41,148
|
40,809
|
41,031
|
34,174
|
34,055
|
|
| Cash, Eq & Invt ShortTerm |
3,499
|
2,329
|
3,438
|
2,175
|
1,368
|
2,598
|
|
| Total Current Assets |
30,362
|
25,848
|
25,582
|
23,513
|
22,283
|
22,291
|
|
| Total Non-Current Assets |
13,512
|
15,300
|
15,227
|
17,518
|
11,891
|
11,764
|
|
| Intangibles |
10,179
|
11,378
|
11,860
|
14,299
|
9,287
|
9,150
|
|
| Total Liabilities |
42,080
|
39,942
|
34,577
|
33,493
|
27,509
|
27,325
|
|
| Total Current Liabilities |
25,323
|
24,671
|
23,919
|
21,427
|
19,796
|
19,385
|
|
| Long Term Debt |
16,757
|
15,271
|
10,658
|
12,066
|
7,713
|
7,940
|
|
| Shareholder equity |
1,790
|
1,203
|
6,230
|
7,537
|
6,646
|
6,713
|
|
| Cash Flow | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| Cash from Operations |
2,004
|
2,226
|
2,770
|
2,938
|
1,101
|
3,198
|
|
| Depreciation |
828
|
929
|
1,012
|
971
|
701
|
580
|
|
| Cash from Investing |
452
|
-422
|
371
|
-5,444
|
-828
|
-4,144
|
|
| Capex |
410
|
373
|
330
|
340
|
474
|
392
|
|
| Cash from Financing |
-1,196
|
-2,915
|
-1,859
|
3,293
|
-1,493
|
368
|
|
| Stock Issued |
-200
|
-350
|
-700
|
-450
|
-951
|
-709
|
|
| Debt (LT) Issued |
-564
|
-1,990
|
-553
|
4,449
|
-44
|
1,516
|
|
| Free Cash Flow |
-165
|
-5,443
|
1,521
|
2,902
|
2,423
|
2,103
|
|
| Ratios | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| Net Profit Margin |
0.7 %
|
-
|
0.0 %
|
1.3 %
|
1.0 %
|
1.2 %
|
|
| NCFO / Op.Income |
316.6 %
|
-
|
438.3 %
|
177.6 %
|
47.8 %
|
133.7 %
|
|
| Current Ratio |
1.2
|
1.0
|
1.1
|
1.1
|
1.1
|
1.1
|
|
| Financial Leverage D/E |
3.76
|
6.04
|
1.46
|
1.27
|
0.82
|
0.83
|
|
| Return on Capital Avg |
8.0 %
|
-47.4 %
|
3.1 %
|
12.7 %
|
11.9 %
|
12.6 %
|
|
| Return on Shareholder Equity |
76.9 %
|
-
|
0.0 %
|
23.9 %
|
20.2 %
|
21.3 %
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available